AstraZeneca Pharmaceuticals LP
USA
10
Total Certificates
3
Valid
1
Facilities
GMP Types
U.S. cGMP (tương đương EU-GMP)
587 Old Baltimore Pike, Newark, DE 19702, USA
| GMP Type | Certificate No. | Issuing Authority | Expiry Date | Status |
|---|---|---|---|---|
| U.S. cGMP (tương đương EU-GMP) |
FEI: 2517100; EI End: 19/07/2023
|
United States Food and Drug Administration (U.S. FDA) | 31/12/2026 | Valid |
| U.S. cGMP (tương đương EU-GMP) |
FEI: 2517100; EI End: 26/04/2024
|
United States Food and Drug Administration (US FDA) | 31/12/2026 | Valid |
| U.S. cGMP (tương đương EU-GMP) |
FEI: 2517100; EI End: 19/07/2023
|
United States Food and Drug Administration (U.S. FDA) | 31/12/2026 | Valid |
| U.S. cGMP (tương đương EU-GMP) |
D3TZ-QDSA
|
United States Food and Drug Administration (U.S. FDA) | 31/12/2022 | Expired |
| U.S. cGMP (tương đương EU-GMP) |
32AT-HTEW
|
United States Food and Drug Administration (U.S. FDA) | 08/12/2022 | Expired |
| U.S. cGMP (tương đương EU-GMP) |
N2S7-DRSG
|
United States Food and Drug Administration (U.S. FDA) | 08/12/2022 | Expired |
| U.S. cGMP (tương đương EU-GMP) |
3FGN-RGWX
|
United States Food and Drug Administration (U.S. FDA) | 08/12/2022 | Expired |
| U.S. cGMP (tương đương EU-GMP) |
V4A6-QVXB
|
United States Food and Drug Administration (U.S. FDA) | 17/06/2021 | Expired |
| U.S. cGMP (tương đương EU-GMP) |
3NAP-Z5ZP; F7QJ-RQ4D
|
United States Food and Drug Administration (U.S. FDA) | 27/03/2021 | Expired |
| U.S. cGMP (tương đương EU-GMP) |
899Y-6R9K
|
United States Food and Drug Administration (U.S. FDA) | 26/03/2021 | Expired |
Actions
Related Drugs
Matched by manufacturer name only — the two datasets share no common identifier, so treat this as a hint.
View All Drugs